| Type of Cancer | Year of Transplant | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | |
| Total Transplants | 89 | 96 | 96 | 98 | 133 | 143 | 182 | 169 | 157 | 166 |
| Skin (Melanoma) | 15 | 12 | 11 | 12 | 12 | 19 | 14 | 14 | 17 | 25 |
| Central Nervous System | 36 | 38 | 34 | 34 | 32 | 36 | 47 | 36 | 38 | 34 |
| Genito-Urinary (1) | 19 | 21 | 20 | 32 | 44 | 43 | 64 | 49 | 42 | 37 |
| Gastro-Intestinal (2) | 2 | 3 | 3 | 3 | 3 | 4 | 6 | 6 | 8 | 4 |
| Larynx/Bronchi/Lung | - | 2 | 1 | 2 | 1 | 1 | 2 | 1 | 5 | 2 |
| Breast/Thyroid | 5 | 8 | 12 | 3 | 12 | 15 | 16 | 18 | 12 | 15 |
| Leukemia/Lymphoma | - | 1 | 1 | 1 | 2 | 4 | 2 | 1 | 3 | 1 |
| Other | 12 | 11 | 14 | 11 | 27 | 21 | 31 | 44 | 32 | 48 |
| Skin (Melanoma) | 16.9% | 12.5% | 11.5% | 12.2% | 9.0% | 13.3% | 7.7% | 8.3% | 10.8% | 15.1% |
| Central Nervous System | 40.4% | 39.6% | 35.4% | 34.7% | 24.1% | 25.2% | 25.8% | 21.3% | 24.2% | 20.5% |
| Genito-Urinary (1) | 21.3% | 21.9% | 20.8% | 32.7% | 33.1% | 30.1% | 35.2% | 29.0% | 26.8% | 22.3% |
| Gastro-Intestinal (2) | 2.2% | 3.1% | 3.1% | 3.1% | 2.3% | 2.8% | 3.3% | 3.6% | 5.1% | 2.4% |
| Larynx/Bronchi/Lung | - | 2.1% | 1.0% | 2.0% | 0.8% | 0.7% | 1.1% | 0.6% | 3.2% | 1.2% |
| Breast/Thyroid | 5.6% | 8.3% | 12.5% | 3.1% | 9.0% | 10.5% | 8.8% | 10.7% | 7.6% | 9.0% |
| Leukemia/Lymphoma | - | 1.0% | 1.0% | 1.0% | 1.5% | 2.8% | 1.1% | 0.6% | 1.9% | 0.6% |
| Other | 13.5% | 11.5% | 14.6% | 11.2% | 20.3% | 14.7% | 17.0% | 26.0% | 20.4% | 28.9% |